Clinical Expertise
The faculty is a major resource for tertiary referral of patients for complex partial nephrectomy with nephron sparing surgery for removal of tumors in patients with decreased renal function or a solitary kidney. There is experience with renal autotransplantation for the rare indications. The Urology faculty, in conjunction with the Cardiothoracic Service, perform frequent radical nephrectomy with associated tumor thrombectomy from the renal vein, inferior vena cava and the heart. The full range of vascular techniques including cardiopulmonary bypass, hypothermic circulatory arrest, veno-veno bypass are available.
The faculty are leaders in the development of minimally invasive laparoscopic radical nephrectomy, partial nephrectomy, and nephroureterectomy. Both percutaneous and laparoscopic radiofrequency heat ablation and cryotherapy of tumors are available. There is a large experience with percutaneous treatment of upper tract renal transitional cell cancer.
Clinical Research
- Minimally Invasive Treatment (see above): active laboratory program complements the clinical effort
- Avastin (antiangiogenesis agent) as adjuvant therapy after surgery for high risk patients
- Interferon, Interlekin II for treatment of advanced disease
- Miniallogeneic Marrow Transplant for treatment of advanced disease
- Camptothecin for treatment of advanced disease
Basic Science Research
- Development of a Circulating Epithelial Antigen Assay for Diagnosis and Detection of Recurrent Disease
- Magnetic Resonance Spectroscopy (MRS) of Kidney Tumors Diagnosis and Characterization of Indeterminate Lesions
For more information about the Department of Urology, contact:
Phone: 214-648-4765, FAX: 214-648-4789
Mailing Address: 5323 Harry Hines Blvd., J8.148, Dallas, TX 75390
